GP

Gary A. Piazza

CP Cell Pathways: 55 patents #2 of 22Top 10%
AP Adt Pharmaceuticals: 9 patents #3 of 4Top 75%
SI Southern Research Institute: 4 patents #32 of 244Top 15%
The Procter & Gamble: 4 patents #2,952 of 10,133Top 30%
UA University Of South Alabama: 3 patents #10 of 69Top 15%
UA University Of Arizona: 3 patents #6 of 91Top 7%
OP Osi Pharmaceuticals: 2 patents #70 of 181Top 40%
Overall (All Time): #23,836 of 4,157,543Top 1%
78
Patents All Time

Issued Patents All Time

Showing 25 most recent of 78 patents

Patent #TitleCo-InventorsDate
11834404 Derivatives of sulindac can protect normal cells against oxidative damage Xi Chen, Herbert Weissbach, Shailaja Kesraju Allani 2023-12-05
11407727 Indenyl compounds, pharmaceutical compositions, and medical uses thereof Xi Chen, Adam B. Keeton, Michael R. Boyd 2022-08-09
11198679 Method of treating or preventing Ras-mediated diseases Xi Chen, Adam B. Keeton, Michael R. Boyd 2021-12-14
11186534 Derivatives of sulindac can protect normal cells against oxidative damage Xi Chen, Herbert Weissbach, Shailaja Kesraju Allani 2021-11-30
11130744 Indenyl compounds, pharmaceutical compositions, and medical uses thereof Xi Chen, Adam B. Keeton, Michael R. Boyd 2021-09-28
11104658 Method of treating or preventing Ras-mediated diseases Xi Chen, Adam B. Keeton, Michael R. Boyd 2021-08-31
10981886 Indenyl compounds, pharmaceutical compositions, and medical uses thereof Xi Chen, Adam B. Keeton, Michael R. Boyd 2021-04-20
10975054 Indenyl compounds, pharmaceutical compositions, and medical uses thereof Xi Chen, Adam B. Keeton, Michael R. Boyd 2021-04-13
10526307 Indenyl compounds, pharmaceutical compositions, and medical uses thereof Xi Chen, Adam B. Keeton, Michael R. Boyd 2020-01-07
10039764 Treatment and diagnosis of cancer and precancerous conditions using PDE10A inhibitors and methods to measure PDE10A expression 2018-08-07
9931315 Method of selectively inhibiting Ras-mediated tumor growth in humans Xi Chen, Adam B. Keeton, Michael R. Boyd 2018-04-03
9862698 Indenyl compounds, pharmaceutical compositions, and medical uses thereof Xi Chen, Adam B. Keeton, Michael R. Boyd 2018-01-09
9388139 Derivatives of celeboxib, use thereof and preparation thereof Ashraf H. Abadi 2016-07-12
9365528 Derivatives of sulindac, use thereof and preparation thereof Robert C. Reynolds, Bini Mathew 2016-06-14
9169247 Tetrahydro-beta-carboline derivatives, synthesis and use thereof Ashraf H. Abadi 2015-10-27
8044048 Derivatives of sulindac, use thereof and preparation thereof Robert C. Reynolds 2011-10-25
7115647 Method of inhibiting neoplastic cells with indole derivatives Rifat Pamukcu 2006-10-03
6875575 Diagnostic methods for neoplasia Rifat Pamukcu 2005-04-05
6610854 Substituted condensation products of N-benzyl-3-indenylacentamides with heterocyclic aldehydes for neoplasia Gerhard Sperl, Paul Gross, Klaus Brendel, Rifat Pamukcu 2003-08-26
6562830 Method of treating a patient having precancerous lesions with phenyl quinazolinone derivatives Rifat Pamukcu 2003-05-13
6500610 Methods for identifying compounds for inhibiting of neoplastic lesions, and pharmaceutical compositions containing such compounds Rifat Pamukcu 2002-12-31
6486155 Method of inhibiting neoplastic cells with isoquinoline derivatives Rifat Pamukcu 2002-11-26
6486158 [4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasia Xiaojing Wang, Gerhard Sperl, Paul Gross, Rifat Pamukcu 2002-11-26
6479520 Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives Rifat Pamukcu 2002-11-12
6440981 Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones Rifat Pamukcu 2002-08-27